Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has approved usage of these checkpoint proteins to treat Cancer.
Brand Names and Generic Names of Drugs for Treatment of Immune Checkpoint Inhibitors for Cancer Treatment
Avelumab
Avelumab is a programmed death ligand-1 (PD-L1) blocking antibody which is prescribed to treat adult and pediatric patients of 12 years and older who suffer from advanced Merkel-cell carcinoma that has spread to other parts of the body.
Cemiplimab-rwlc
Cemiplimab-rwlc is prescribed to treat cutaneous squamous skin cancer with tumors that are either locally advanced or that have moved to other body parts
Advertisement
Nivolumab
Nivolumab is a monoclonal antibody and a PD-1 inhibitor (programmed death receptor inhibitor) which is prescribed for cancer treatment.
Pembrolizumab
Pembrolizumab injection is prescribed to treat different types of cancer such as Melanoma or skin cancer, Non-Small-Cell lung cancer (NSCLC)...
Advertisement
